Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on VERTEX PHARMACEUTICALS INC
02:48pDJBristol-Myers Expands Board, Boosts Buybacks Amid Activist Pressure
02/07 VERTEX PHARMACEUTICALS INCORPORATED : Stock Price of Vertex Pharmaceuticals Inco..
01/28 VERTEX PHARMACEUTICALS INCORPORATED : U.S. Patents Awarded to Inventors in Calif..
01/28 INGERSOLL RAND : U.S. Patents Awarded to Inventors in New Jersey (Jan. 28)
01/25 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
01/25 VERTEX PHARMACEUTICALS INCORPORATED : tops Street 4Q forecasts
01/25 VERTEX PHARMACEUTICALS INCORPORATED : Reports Full-Year and Fourth-Quarter 2016 ..
01/19 MERCK KGAA : Darmstadt, Germany, Licenses Four Oncology Research and Development..
01/19 MERCK KGAA : Darmstadt, Germany Licenses Four Oncology Research and Development ..
01/14 VERTEX PHARMACEUTICALS INCORPORATED : Merck expands oncology portfolio with four..
01/12 VERTEX PHARMACEUTICALS INCORPORATED : Announces Upcoming Presentation at the J.P..
01/12 VERTEX PHARMACEUTICALS INCORPORATED : Patent Issued for Methods of Regioselectiv..
01/11 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K Entry into a Material ..
01/11 VERTEX PHARMACEUTICALS INC / MA : Entry into a Material Definitive Agreement (fo..
01/11 VERTEX PHARMACEUTICALS INCORPORATED : Merck KGaA, Darmstadt, Germany Licenses Fo..
01/09 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K Results of Operations ..
01/09 VERTEX PHARMACEUTICALS INCORPORATED : INC / MA Results of Operations and Financi..
01/09 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
01/09 VERTEX PHARMACEUTICALS INCORPORATED : Pharma Provides Update On Business And Fin..
01/08 VERTEX PHARMACEUTICALS INCORPORATED : Provides Update on Business and Financial ..
01/08 INSIDER TRADING ACTIVITY VERTEX PHAR : VRTX) – Director Sold 6,500 shares ..
01/08 VERTEX PHARMACEUTICALS INCORPORATED : Strs Ohio Boosts Stake in Vertex Pharmaceu..
01/04 VERTEX PHARMACEUTICALS INCORPORATED : Announces Upcoming Presentation at the J.P..
01/02 VERTEX PHARMACEUTICALS INCORPORATED : Analysts Recent Ratings Changes for Vertex..
2016 U.S. stock market performance in 2016
2016 VERTEX PHARMACEUTICALS INCORPORATED : Announces German Reimbursement Agreement f..
2016 VERTEX PHARMACEUTICALS INCORPORATED : California Public Employees Retirement Sys..
2016 NASDAQ 100 MOVERS : Ctas, ntes
2016 VERTEX PHARMACEUTICALS INCORPORATED : Announces German Reimbursement Agreement f..
2016 VERTEX PHARMACEUTICALS INCORPORATED : The Vertex Pharmaceuticals Inc. (Vrtx) Rel..
2016 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K Departure of Directors..
2016 VERTEX PHARMACEUTICALS INC / MA : Change in Directors or Principal Officers (for..
2016 NASDAQ 100 MOVERS : Bmrn, nflx
2016 VERTEX PHARMACEUTICALS INCORPORATED : Positive Phase 3 Study of ORKAMBI® in Chil..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Assigned Patent
2016 NASDAQ 100 MOVERS : Alxn, nvda
2016 VERTEX PHARMACEUTICALS INCORPORATED : to Present at the Credit Suisse Healthcare..
2016 VERTEX PHARMACEUTICALS INCORPORATED : (VRTX) Pops 11.92% for November 09
2016 VERTEX PHARMACEUTICALS INCORPORATED : Positive Phase 3 Study of ORKAMBI® in Chil..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Announces Planned Initiation of Phase 2 St..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Presents Long-Term Data Demonstrating that..
2016 VERTEX PHARMACEUTICALS INCORPORATED : to Present at the Credit Suisse Healthcare..
2016 VERTEX PHARMACEUTICALS INCORPORATED : INC / MA Management's Discussion and Analy..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Presents Long-Term Data Demonstrating that..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Falls 2.51% for October 24
2016 VERTEX PHARMACEUTICALS INC / MA : Results of Operations and Financial Condition,..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Pharma reports 3Q loss
2016 VERTEX PHARMACEUTICALS INCORPORATED : Reports Third Quarter 2016 Financial Resul..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Announces Planned Initiation of Phase 2 St..
2016 NASDAQ 100 MOVERS : Vrtx, tmus
2016 S&P 500 MOVERS : Col, qrvo
2016 VERTEX PHARMACEUTICALS INCORPORATED : to Announce Third Quarter 2016 Financial R..
2016 VERTEX PHARMACEUTICALS INCORPORATED : VRTX) Files An 8-K
2016 VERTEX PHARMACEUTICALS INC / MA : Entry into a Material Definitive Agreement (fo..
2016 VERTEX PHARMACEUTICALS INC / MA : Entry into a Material Definitive Agreement, Ot..
2016 VERTEX PHARMACEUTICALS INCORPORATED : to Announce Third Quarter 2016 Financial R..
2016 VERTEX PHARMACEUTICALS INCORPORATED : VRTX): Get In While Markets Look The Othe..
2016 VERTEX PHARMACEUTICALS INCORPORATED : U.S. Food and Drug Administration Approves..
2016 NASDAQ 100 MOVERS : Bmrn, bbby
2016 New Crystallization Development Methods Revealed in On-Demand Webinars from M..
2016 New Crystallization Development Methods Revealed in On-Demand Webinars from M..
2016 NASDAQ 100 MOVERS : Expe, wdc
2016 VERTEX PHARMACEUTICALS INCORPORATED : Investigators at Vertex Pharmaceuticals In..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Researchers from Vertex Pharmaceuticals In..
2016 VERTEX PHARMACEUTICALS INCORPORATED : to Present at Upcoming Investor Conference..
2016 VERTEX PHARMACEUTICALS INCORPORATED : Patent Issued for Solid Forms of 3-(6-(1-(..
2016 VERTEX PHARMACEUTICALS INCORPORATED : to Present at Upcoming Investor Conference..
2016 NASDAQ 100 MOVERS : Gild, tmus
2016 S&P 500 MOVERS : Mro, regn
2016 VERTEX PHARMACEUTICALS INCORPORATED : Provides Update on Ongoing Phase 3 Program..
2016 OPHTHOTECH : Announces Election of Ian F. Smith, Vertex Executive Vice President..
2016 VERTEX PHARMACEUTICALS : Trek Therapeutics Acquires Two Antiviral Inhibitors Fro..
2016 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
2016 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Processes for P..
2016DJU.S. HOT STOCKS : Hot Stocks to Watch
1  2  3  4  5  6  7  8Next
Advertisement
Financials ($)
Sales 2017 2 037 M
EBIT 2017 419 M
Net income 2017 148 M
Finance 2017 876 M
Yield 2017 -
P/E ratio 2017 118,15
P/E ratio 2018 44,53
EV / Sales 2017 10,3x
EV / Sales 2018 7,93x
Capitalization 21 909 M
More Financials
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 99,0 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jeffrey M. Leiden Chairman, President & Chief Executive Officer
Ian F. Smith EVP, Chief Operating & Financial Officer
Jeffrey A. Chodakewitz Chief Medical Officer & Executive Vice President
David Matthew Altshuler Chief Scientific Officer & EVP-Global Research
Joshua S. Boger Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..19.90%21 909
AMGEN, INC.18.52%127 620
CELGENE CORPORATION4.67%94 258
GILEAD SCIENCES, INC.-2.46%92 024
REGENERON PHARMACEUTIC..1.11%39 375
ACTELION LTD21.09%28 938
More Results